Tuesday, May 28, 2013

Equipose 200

Boldenone Undecylenate has become a very popular steroid with athletes and bodybuilders due to the fact that it has very low side effects and has anabolic properties which promote a steady gain in quality muscle mass over time. GP Bold 200 (Boldenone Undecylenate) was tagged with the name Equipose® when it first became available as a veterinary steroid and was widely used in racehorses.

Equipose 200 (Boldenone Undecylenate), as it is often called, can be effectively incorporated in both "cutting" and "bulking" cycles due to the well balanced effects of this anabolic substance. GP Bold 200 (Equipoise) aromatizes very little, and therefore produces almost no estrogenic side effects such as water retention or "gyno" (the development of female tissue under the nipples in males resulting in unattractive and often painful lumps in this area), and therefore is a favorite among bodybuilders who are looking to make solid gains without the extra bloat, or are nearing contest.

Equipose 200 (Boldenone Undecylenate) also dramatically increases protein synthesis and red blood cell count meaning that nutrients are transported throughout the body much more effectively. Because of this, Equipose® is able to make much more use of less food, enhancing its capabilities as an effective hormone to use when "cutting" and a bodybuilder is trying to reduce calories to get into contest shape. Also, the increased red blood cell count caused by Boldenone Undecylenate also increases oxygen transportation throughout the body, thus giving athletes and bodybuilders much more endurance and the capability to endure cardio sessions for much longer periods of time, which obviously makes Equipose 200 (Boldenone Undecylenate) even more popular among those looking to shed bodyfat.

Users of  Equipose 200 (Boldenone Undecylenate) also report a dramatic increase in vascularity, which can also be attributed to the oxidizing benefits of Equipoise. Bodybuilders using Equipose 200 (Boldenone Undecylenate)  in a cutting cycle often look to stack it with an oral steroid such as Stanozolole or Oxandrolone to further increase anabolic activity while keeping estrogenic side effects out of the picture.

Equipose 200 (Boldenone Undecylenate) also has properties which make it very favorable amongst Bodybuilders looking to incorporate it into their bulking cycles. Users of Equipose 200 (Boldenone Undecylenate) often report an increase in appetite and the ability to eat more food easily when trying to gain weight in the offseason. The mild nature and steady gains produced by Equipose 200 (Boldenone Undecylenate) also make it very effective for those looking to do longer cycles (12-20 weeks ), where as most users note a continuous gain in muscle mass and strength over this time and credit the steroid with helping the muscles maintain a more defined, vascular tone throughout bulking .

Bodybuilders looking for size often stack Equipoise with other anabolic drugs such as a testosterone preparation (GP Test Enanth 250, GP Test Cyp 250, GP Test Prop 100 etc.) and/or Deca-Durabolin . Bodybuilders looking to bulk might also incorporate an oral compound into this stack such as GP Oxan or GP Methan.

Women bodybuilders are also fond of Equipoise due to its mild nature and low androgenic properties. The most often side effect of the drug being an increase in libido, women find that the drug rarely causes any masculizing side effects when kept in a reasonable dosage range.

Male bodybuilders generally buy Equipose 200 (Boldenone Undecylenate) in doses of 300-800mg's a week for 8-20wks, depending on goals, while women bodybuilders often find a dosage of 50-100mg's a week to be very effective for making quality gains while keeping side effects to a minimum. Equipose 200 (Boldenone Undecylenate) has a long half life (7-10) days and is most commonly injected twice per week to keep blood concentrations as steady as possible.

Tuesday, May 21, 2013

Do Men's and Women's Hearts Burn Fuel Differently?

Researchers at the University of Illinois at Chicago College of Medicine will study gender differences in how the heart uses and stores fat  -  its main energy source - and how changes in fat metabolism play a role in heart disease.


When stressed, the heart changes how it uses fuel for energy. These changes may play a major role in the development of heart disease and are different in men and women, says E. Douglas Lewandowski, director of the UIC Center for Cardiovascular Research. The changes occur long before any symptoms, he said, and may be key to early diagnosis and treatment.
Lewandowski uses imaging techniques he developed to see fat molecules and the rate at which they are being burned in beating hearts. In healthy hearts, the balance between using fat for energy and storing it in tiny droplets within the cells is in a dynamic equilibrium. 
When a female heart is stressed, such as through chronic disease like hypertension, it becomes much less efficient at metabolizing fat, Lewandowski says. When a male heart is stressed, it starts using more sugar as fuel. These changes in the heart can also affect how fat is stored and used in other parts of the body.
"Because the heart is the body's number-one consumer of fat, when it starts using fat differently, there are consequences throughout the entire body," Lewandowski said. He thinks that changes in fat metabolism in the heart may send out signals to fat cells in other parts of the body to store more fat, and to insulin-producing cells in the pancreas that may trigger the onset of diabetes, which is often present along with heart disease.
Lewandowski will further investigate how gender differences in fat metabolism are related to the development of heart disease in men and women. He will also look at how higher levels of fat accumulation in heart cells may cause stiffness and lower the efficiency of heart muscle contraction. Understanding these changes may help identify targets for therapies, or lead to better diagnostic tests for heart disease.






Friday, May 10, 2013

No More Reflux!!!!

For years, Majed Khalifa's severe reflux prevented him from sleeping at night and, because of his disease, he couldn't even drink coffee to help him get through the day. He was taking medication for gastroesphogeal reflux disease (GERD), and when it stopped working, he decided to try something new.


Dr. Pat Reardon, surgical director of the Reflux Center at The Methodist Hospital in Houston, performed a new minimally-invasive outpatient surgery that ended years of severe discomfort in a matter of hours.
"I literally felt 100 percent better as soon as I got home," Khalifa said. "I haven't had a reoccurrence of reflux symptoms since the surgery and it's been more than a month."
GERD is a chronic, progressive disease that affects millions of people. It results when a bad valve at the lower end of the esophagus gets pulled open too easily from the pressure down below the stomach. The opening of the valve allows the contents of the stomach to wash back into the esophagus causing heartburn, regurgitation, loss of sleep and, in some cases, dietary restrictions.
The new LINX® Reflux Management System from Torax Medical was recently approved by the Food and Drug Administration (FDA) to combat GERD. The system, composed of a small implant made up of intertwined titanium beads with magnetic cores, is designed to prevent the bad valve at the end of the esophagus from opening. The magnetic attraction between the beads allows the food to go by when you eat. The magnets then snap back into place to prevent the valve from being pulled open from below by the stomach.


Thursday, May 2, 2013

Coffee and green tea may help lower stroke risk

Green tea and coffee may help lower your risk of having a stroke, especially when both are a regular part of your diet.


  • People who drank at least one cup of coffee daily had about a 20 percent lower risk of stroke compared to those who rarely drank it.
  • People who drank two to three cups of green tea daily had a 14 percent lower risk of stroke and those who had at least four cups had a 20 percent lower risk, compared to those who rarely drank it.
  • People who drank at least one cup of coffee or two cups of green tea daily had a 32 percent lower risk of intracerebral hemorrhage, compared to those who rarely drank either beverage. (Intracerebral hemorrhage happens when a blood vessel bursts and bleeds inside the brain. About 13 percent of strokes are hemorrhagic.)